by rss feed | May 6, 2022 | biotechs, FDA, News Feeds, perinatal cell therapy, perinatal stem cells
If there’s one area of biologics where the FDA has been consistently busy lately it’s the perinatal cell therapy space. The agency has made it clear in the last year that allogeneic birth-related cell products are often drugs requiring premarket approval....
